Commonwealth Equity Services, LLC Evogene Ltd. Transaction History

Commonwealth Equity Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$0.7 - $0.98 $7,762 - $10,867	11,089 New	11,089 $8,000
Q4 2022 Feb 07, 2023	SELL	$0.61 - $8.13 $3,283 - $43,763	-5,383 Reduced 32.16%	11,355 $7,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $8.65 $1,105 - $13,104	1,515 Added 9.95%	16,738 $13,000
Q2 2022 Jul 19, 2022	BUY	$0.75 - $1.33 $375 - $665	500 Added 3.4%	15,223 $11,000
Q1 2022 May 04, 2022	SELL	$1.09 - $1.83 $545 - $915	-500 Reduced 3.28%	14,723 $19,000
Q4 2021 Jan 31, 2022	BUY	$1.63 - $2.83 $1,833 - $3,183	1,125 Added 7.98%	15,223 $24,000
Q3 2021 Oct 29, 2021	SELL	$2.45 - $3.45 $1,531 - $2,156	-625 Reduced 4.25%	14,098 $37,000
Q2 2021 Aug 11, 2021	BUY	$3.3 - $5.02 $990 - $1,505	300 Added 2.08%	14,723 $50,000
Q1 2021 May 04, 2021	SELL	$4.29 - $9.94 $26,640 - $61,727	-6,210 Reduced 30.1%	14,423 $72,000
Q4 2020 Feb 11, 2021	BUY	$2.41 - $5.63 $49,725 - $116,163	20,633 New	20,633 $96,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.